Chantix retains black box warning label
Pfizer will have to continue to put a black box label on its smoking-cessation drug Chantix for the time being. The U.S. Food and Drug Administration released the documents of its expert panel Oct. 16,...
View ArticleDefect caused by Emcure Pharmaceuticals leads companies to recall nonsterile...
The U.S. Food and Drug Administration announced two companies recalled medical products in mid-February due to their not being sterile. Sagent Pharmaceuticals recalled Atracurium Besylate Injections in...
View ArticleFDA Issues Drug Safety Advisory for Increased Risk of Heart Attack and Stroke...
The FDA today announced that it will require manufacturers of testosterone replacement therapy products to update labeling to: Warn of a possible increased cardiovascular risk associated with...
View ArticleHow safe is acetaminophen?
Researchers at the Leeds Institute of Rheumatic and Musculoskeletal Medicine in England found acetaminophen, commonly known as Tylenol, may not be as safe as physicians and consumers think....
View ArticleFDA Safety Advisory: Testosterone Drugs May Increase Risk of Heart Attack and...
On March 3, 2015, the FDA announced that it will require manufacturers of testosterone replacement therapy products to update the drugs’ labeling to warn doctors and patients of a possible increased...
View ArticleFDA: Testosterone Therapy is NOT Approved to Treat Low Testosterone in Aging Men
On March 3, 2015, the FDA announced that it will require manufacturers of testosterone drugs to change their labels to notify patients and doctors that testosterone has not been tested or approved to...
View ArticleToo many elderly patients with dementia are prescribed antipsychotic medications
Many elderly Americans receive dangerous antipsychotic medications, according to a report from the U.S. Government Accountability Office. Antipsychotic medications are often given to elderly patients...
View ArticleHospira recalls sodium chloride injectable
Hospira, a major provider of injectable drugs, announced a recall due to a foreign particle that was present in one of its products, according to a release from the U.S. Food and Drug Administration....
View ArticleHeart drug Brilinta increases risk of blood loss
Pharmaceutical company AstraZeneca released the results of its 21,000-patient study for its new flagship heart drug Brilinta March 16 to mixed reviews after the risk of excessive bleeding became...
View ArticleJury Awards $38 Million to Girl Injured by Abbott’s Drug Depakote
Hundreds of lawsuits have been filed against Abbott Laboratories and Abbvie Inc. These lawsuits claim that Depakote, a drug manufactured and marketed by the Defendants, caused serious birth defects in...
View Article
More Pages to Explore .....